259 related articles for article (PubMed ID: 19772377)
21. Effect of SBE7-beta-cyclodextrin complexation on carbamazepine release from sustained release beads.
Smith JS; Macrae RJ; Snowden MJ
Eur J Pharm Biopharm; 2005 May; 60(1):73-80. PubMed ID: 15848059
[TBL] [Abstract][Full Text] [Related]
22. Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrin.
Nair AB; Attimarad M; Al-Dhubiab BE; Wadhwa J; Harsha S; Ahmed M
Drug Deliv; 2014 Nov; 21(7):540-7. PubMed ID: 24215288
[TBL] [Abstract][Full Text] [Related]
23. Estradiol sustained release from high affinity cyclodextrin hydrogels.
Rodriguez-Tenreiro C; Alvarez-Lorenzo C; Rodriguez-Perez A; Concheiro A; Torres-Labandeira JJ
Eur J Pharm Biopharm; 2007 Apr; 66(1):55-62. PubMed ID: 17081737
[TBL] [Abstract][Full Text] [Related]
24. A novel pH-dependent gradient-release delivery system for nitrendipine: I. Manufacturing, evaluation in vitro and bioavailability in healthy dogs.
Yang M; Cui F; You B; You J; Wang L; Zhang L; Kawashima Y
J Control Release; 2004 Aug; 98(2):219-29. PubMed ID: 15262414
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, and in vitro evaluation of new amphiphilic cyclodextrin-based nanoparticles for the incorporation and controlled release of acyclovir.
Perret F; Duffour M; Chevalier Y; Parrot-Lopez H
Eur J Pharm Biopharm; 2013 Jan; 83(1):25-32. PubMed ID: 23072941
[TBL] [Abstract][Full Text] [Related]
26. Application of mixtures of polymeric carriers for dissolution enhancement of fenofibrate using hot-melt extrusion.
Kalivoda A; Fischbach M; Kleinebudde P
Int J Pharm; 2012 Jun; 429(1-2):58-68. PubMed ID: 22440149
[TBL] [Abstract][Full Text] [Related]
27. Design and evaluation of ocular drug delivery system for controlled delivery of gatifloxacin sesquehydrate: In vitro and in vivo evaluation.
Patel UL; Chotai NP; Nagda CD
Pharm Dev Technol; 2012; 17(1):15-22. PubMed ID: 20649410
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
[TBL] [Abstract][Full Text] [Related]
29. Preparation and evaluation of gastroretentive floating tablets of acyclovir.
Garg R; Gupta GD
Curr Drug Deliv; 2009 Oct; 6(5):437-43. PubMed ID: 19751200
[TBL] [Abstract][Full Text] [Related]
30. Cross-linked β-cyclodextrin and carboxymethyl cellulose hydrogels for controlled drug delivery of acyclovir.
Malik NS; Ahmad M; Minhas MU
PLoS One; 2017; 12(2):e0172727. PubMed ID: 28245257
[TBL] [Abstract][Full Text] [Related]
31. Effect of various surfactants and their concentration on controlled release of captopril from polymeric matrices.
Nokhodchi A; Hassan-Zadeh D; Monajjem-Zadeh F; Taghi-Zadeh N
Acta Pharm; 2008 Jun; 58(2):151-62. PubMed ID: 18515225
[TBL] [Abstract][Full Text] [Related]
32. Bi-polymeric Spongy Matrices Through Cross-linking Polymerization: Synthesized and Evaluated for Solubility Enhancement of Acyclovir.
Asghar S; Akhtar N; Minhas MU; Khan KU
AAPS PharmSciTech; 2021 Jun; 22(5):181. PubMed ID: 34129154
[TBL] [Abstract][Full Text] [Related]
33. Encapsulation of Acyclovir in new carboxylated cyclodextrin-based nanosponges improves the agent's antiviral efficacy.
Lembo D; Swaminathan S; Donalisio M; Civra A; Pastero L; Aquilano D; Vavia P; Trotta F; Cavalli R
Int J Pharm; 2013 Feb; 443(1-2):262-72. PubMed ID: 23279938
[TBL] [Abstract][Full Text] [Related]
34. Psyllium: a promising polymer for sustained release formulations in combination with HPMC polymers.
Kaialy W; Emami P; Asare-Addo K; Shojaee S; Nokhodchi A
Pharm Dev Technol; 2014 May; 19(3):269-77. PubMed ID: 23506265
[TBL] [Abstract][Full Text] [Related]
35. Topical delivery of acyclovir and ketoconazole.
Jacobs GA; Gerber M; Malan MM; du Preez JL; Fox LT; du Plessis J
Drug Deliv; 2016; 23(2):631-41. PubMed ID: 25005585
[TBL] [Abstract][Full Text] [Related]
36. Unfolding type gastroretentive film of Cinnarizine based on ethyl cellulose and hydroxypropylmethyl cellulose.
Verma S; Nagpal K; Singh SK; Mishra DN
Int J Biol Macromol; 2014 Mar; 64():347-52. PubMed ID: 24370473
[TBL] [Abstract][Full Text] [Related]
37. Dual sustained release delivery system for multiple route therapy of an antiviral drug.
Ramyadevi D; Sandhya P
Drug Deliv; 2014 Jun; 21(4):276-92. PubMed ID: 24134619
[TBL] [Abstract][Full Text] [Related]
38. Formulation and development of gastroretentive drug delivery system for ofloxacin.
Ali J; Hasan S; Ali M
Methods Find Exp Clin Pharmacol; 2006 Sep; 28(7):433-9. PubMed ID: 17003848
[TBL] [Abstract][Full Text] [Related]
39. The role of lipid-based drug delivery systems for enhancing solubility of highly selective antiviral agent acyclovir.
Kazi M; Al-Amri KA; Alanazi FK
Pharm Dev Technol; 2017 May; 22(3):312-321. PubMed ID: 26458371
[TBL] [Abstract][Full Text] [Related]
40. Cyclodextrin multicomponent complexation and controlled release delivery strategies to optimize the oral bioavailability of vinpocetine.
Ribeiro LS; Falcão AC; Patrício JA; Ferreira DC; Veiga FJ
J Pharm Sci; 2007 Aug; 96(8):2018-28. PubMed ID: 17530626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
